QUILT-3.033: Haploidentical Donor Natural Killer (NK) Cell Infusion With Subcutaneous ALT-803 in Adults With Refractory or Relapsed Acute Myelogenous Leukemia
Latest Information Update: 19 Jul 2023
At a glance
- Drugs Nogapendekin alfa inbakicept (Primary) ; Cyclophosphamide; Fludarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms QUILT-3.033
- 30 Oct 2020 Status changed from active, no longer recruiting to completed.
- 13 Feb 2020 Status changed from suspended to active, no longer recruiting.
- 14 Sep 2018 Status changed from recruiting to suspendeddue to interim analysis